Matthieu Collin
We have observed 106 EP applications Matthieu Collin has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
EP12729116
NKp46-MEDIATED NK CELL TUNING
- IPC classification:
- A61K 38/17, A61K 39/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Innate Pharma SA
- Applicant:
- Université de la Méditerranée - Aix-Marseille II
- Agent:
- Matthieu Collin, Inserm Transfert
- Agent:
- Lukas Völlmy, Innate Pharma SA
- Status:
- █ GRANT OF PATENT INTENDED
EP14721259
METHODS AND KITS FOR TESTING THE GENOTOXICITY OF AN AGENT
- IPC classification:
- G01N 33/50
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Rouen
- Applicant:
- Centre Hospitalier Universitaire de Rouen
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14718603
METHODS FOR STIMULATING ANTIGEN-SPECIFIC T CELL RESPONSES
- IPC classification:
- G01N 33/50, G01N 33/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14725123
FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE
- IPC classification:
- G01N 33/74
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14728216
BIOMARKER OF REHOSPITALIZATION AFTER HEART FAILURE
- IPC classification:
- G01N 33/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14726637
USE OF URINARY HIV NUCLEIC ACIDS TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)
- IPC classification:
- C12Q 1/70
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14732529
RAC1 INHIBITORS FOR INDUCING BRONCHODILATION
- IPC classification:
- A61K 31/496, A61K 45/00, A61P 11/06, A61P 11/08
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Centre Hospitalier Universitaire Nantes
- Agent:
- Cabinet Lavoix
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14729335
ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER
- IPC classification:
- A61K 39/00, C07K 16/32
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14730859
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA
- IPC classification:
- A61K 31/7125, A61P 7/00, A61P 17/00, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14731639
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING GLUCOCORTICOID-INDUCED CORNEAL OR SKIN THINNING
- IPC classification:
- A61K 9/00, A61K 9/06, A61K 9/08, A61K 31/573, A61K 31/585, A61P 17/00, A61P 27/02, A61P 29/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14735542
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- IPC classification:
- A61K 38/20, A61P 11/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14735525
INTERLEUKIN 15 (IL-15) ANTAGONISTS AND USES THEREOF FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
- IPC classification:
- A61K 38/20, C07K 14/54, C12N 15/00, C12N 15/62
- Applicant:
- Université d'Angers
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14733199
METHODS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINA OF A SUBJECT
- IPC classification:
- C07K 14/47, C12N 7/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14735579
NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF
- IPC classification:
- A61K 38/00, C07K 14/47, C12N 5/00
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14737236
METHODS FOR PERFORMING ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING IN THE RETINA OF A SUBJECT IN NEED THEREOF
- IPC classification:
- A61K 31/7088, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Cabinet Lavoix
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14744575
METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
- IPC classification:
- G01N 33/569
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14741881
ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER
- IPC classification:
- A61K 39/395, A61P 35/00, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14746985
ANTI-CLAUDIN 1 ANTIBODIES AND USES THEREOF
- IPC classification:
- A61K 39/395, A61P 35/00, C07K 16/18
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14755794
IMMUNOADJUVANT COMPOSITIONS AND USES THEREOF
- IPC classification:
- A61K 39/39
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14766928
METHODS FOR DETERMINING HUMAN SPERM QUALITY
- IPC classification:
- C12Q 1/48, G01N 33/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Centre Hospitalier Régional et Universitaire de Lille
- Agent:
- Matthieu Collin, Inserm Transfert
- Agent:
- Valérie Schwalek, SCB S.A.S.
- Status:
- █ GRANT OF PATENT INTENDED
EP14766458
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS
- IPC classification:
- A61K 31/712, A61P 11/00, A61P 43/00, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14766503
LENTIVIRAL VECTORS HAVING A MUTATED INTEGRASE PROTEIN AND USES THEREOF
- IPC classification:
- C07K 14/005, C12N 15/86
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14766481
METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY
- IPC classification:
- A61K 31/513, A61P 25/08
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Bordeaux
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ GRANT OF PATENT INTENDED
EP14786873
METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF POLYOMAVIRUS INFECTIONS
- IPC classification:
- A61K 31/7068, A61P 13/12, A61P 31/20, A61P 35/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Les Hospices Civils de Lyon
- Applicant:
- Université Claude Bernard Lyon I (UCBL)
- Applicant:
- Ecole Normale Supérieure de Lyon
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14793193
NEW ALZHEIMER'S DISEASE ANIMAL MODEL
- IPC classification:
- A01K 67/027, C07K 14/47, C12N 15/85, C12N 15/86, G01N 33/50
- Applicant:
- CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP13836207
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCERS
- IPC classification:
- A61K 38/17, A61P 35/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14799415
A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT
- IPC classification:
- A61K 38/16, A61K 39/39, A61P 31/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Nice (Université Nice Sophia Antipolis)
- Applicant:
- Centre Hospitalier Universitaire de Nice
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14808905
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS
- IPC classification:
- A61K 31/396, A61P 7/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14806623
MAFB MUTANTS AND USES THEREOF
- IPC classification:
- C07K 14/47, C07K 14/82
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Applicant:
- Europäisches Laboratorium für Molekularbiologie (European Molecular Biology Laboratory (EMBL), Heidelberg)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14809410
METHODS FOR ADHERING TISSUE SURFACES AND MATERIALS AND BIOMEDICAL USES THEREOF
- IPC classification:
- A61K 9/70, A61K 31/695, A61K 33/00, A61K 38/48, A61K 45/06, A61K 47/02, A61L 24/00, A61L 26/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Paris 13 University (Universite Paris 13 Nord)
- Applicant:
- Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14833136
METHODS FOR THE PREVENTION AND TREATMENT OF DIABETIC CARDIOMYOPATHY USING MIR-424/322
- IPC classification:
- A61K 48/00, C12N 15/864
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP14809644
METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING
- IPC classification:
- C07K 16/18, C07K 16/28, C07K 16/30, C12N 15/113
- Applicant:
- Assistance Publique Hôpitaux de Marseille
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP14824852
COMBINATION OF AN ARSENIC COMPOUND AND AT LEAST ONE RETINOID FOR TREATING ACUTE MYELOID LEUKEMIA
- IPC classification:
- A61K 31/203, A61K 31/285, A61K 33/36, A61P 35/02
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION IN PROGRESS
EP15700100
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR REDUCING METASTATIC DISSEMINATION
- IPC classification:
- A61K 31/164, A61P 35/04, G01N 33/50
- Applicant:
- Université de Bourgogne Dijon
- Applicant:
- Université de Rennes 1
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Applicant:
- University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
- Applicant:
- Ecoles des Hautes en Sante Publique (EHESP)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15703742
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
- IPC classification:
- A61K 31/47, A61K 31/4709, A61K 38/17, A61K 38/22, A61K 39/00, A61K 45/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15703741
METHODS FOR THE PREVENTION AND THE TREATMENT OF EXTRACAPILLARY GLOMERULONEPHRITIS
- IPC classification:
- A61K 31/713, A61P 13/12, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15702743
SOLUBLE MONOMERIC ANTI-MULLERIAN HORMONE RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF
- IPC classification:
- C07K 14/71, C12N 15/62
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Cabinet Plasseraud
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15705274
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- IPC classification:
- A61K 31/7032, A61K 39/00, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15704806
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY THE NRP-1/OBR COMPLEX SIGNALING PATHWAY
- IPC classification:
- G01N 33/50, G01N 33/574
- Applicant:
- Université de Bourgogne Dijon
- Applicant:
- CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15705594
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
- IPC classification:
- C07K 14/47, C12N 15/62
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15708510
CARBAPENEMASE AND ANTIBACTERIAL TREATMENT
- IPC classification:
- C12N 9/86
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15709213
DIAGNOSIS METHOD FOR LUPUS
- IPC classification:
- G01N 33/564
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15708545
METHODS AND KITS FOR CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCLs) INTO GCB-DLBCLs OR INTO ABC-DLBCLs
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Rouen
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15710188
METHODS FOR PREDICTING ACUTE REJECTION IN HEART RECIPIENTS
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15710530
A METHOD FOR INDUCING HUMAN CHOLANGIOCYTE DIFFERENTIATION
- IPC classification:
- C12N 5/071
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15711162
TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS EPAC1 INHIBITORS FOR THE TREATMENT OF MYOCARDIAL INFARCTION INJURY
- IPC classification:
- A61K 31/47, A61K 45/06, A61P 9/10
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15712159
NEW BIOMARKER FOR OUTCOME IN AML PATIENTS
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15713503
AN ISOLATED DONOR MHC-DERIVED PEPTIDE AND USES THEREOF
- IPC classification:
- C07K 14/435
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15713778
NEW METHOD FOR PRODUCING OUTER MEMBRANE VESICLES
- IPC classification:
- A61K 39/00, C12N 1/06
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Institut National de la Recherche Agronomique (INRA)
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15716069
ANTIBODIES FOR THE PREVENTION OR THE TREATMENT OF BLEEDING EPISODES
- IPC classification:
- A61K 39/395, A61P 7/04, C07K 16/36
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Agent:
- Nicolas Marro, Cabinet Beau de Loménie (CBDL)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15715758
POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY
- IPC classification:
- C07K 14/435
- Applicant:
- University of Nottingham
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Bordeaux
- Applicant:
- University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15718902
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS
- IPC classification:
- A61K 38/17, A61K 38/43, A61K 38/46, A61P 7/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15724533
NEW BIOMARKER FOR AML
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15723913
MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION
- IPC classification:
- A61K 31/423, A61P 11/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Agent:
- Icosa
- Status:
- █ EXAMINATION REQUESTED
EP15725258
NEW METHOD FOR TREATING MELANOMA
- IPC classification:
- A61K 38/17, A61K 39/395, A61P 35/00, C07K 16/24, C07K 16/28, C07K 16/30
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15723721
ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF
- IPC classification:
- C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15729772
ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF
- IPC classification:
- A61K 33/24, A61K 39/00, A61K 39/395, C07K 16/26
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15726593
ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF
- IPC classification:
- A61K 39/00, A61P 35/00, C07K 16/18, C07K 16/30
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15728519
PHARMACEUTICAL COMPOSITIONS COMPRISING AN AT2R AGONIST FOR TREATING PAIN
- IPC classification:
- A61K 31/365, A61P 29/00
- Applicant:
- Université d'Angers
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- University of Nice (Université Nice Sophia Antipolis)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15726633
PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES
- IPC classification:
- A61K 38/16, C07K 14/005
- Applicant:
- ICM - Institut du Cerveau et da la Moelle Epinière
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15731531
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
- IPC classification:
- A61K 31/165, A61P 35/02
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15728015
METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER
- IPC classification:
- G01N 33/574
- Applicant:
- Université de Bourgogne Dijon
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Cabinet Plasseraud
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15731951
METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre Hospitalier Universitaire de Montpellier
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15731937
FREE NUCLEIC ACIDS AND MIRNA AS NON-INVASIVE METHOD FOR DETERMINING EMBRYO QUALITY
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre Hospitalier Universitaire de Montpellier
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15734351
ANTI- MGLUR2 CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF
- IPC classification:
- A61K 39/395, A61P 25/00, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15735940
A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
- IPC classification:
- A61K 39/00, G01N 33/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15734409
METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN
- IPC classification:
- A61K 31/713, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15738898
METHODS FOR THE INTERCELLULAR TRANSFER OF ISOLATED MITOCHONDRIA IN RECIPIENT CELLS
- IPC classification:
- A61K 35/12, C12N 5/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre Hospitalier Universitaire de Montpellier
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15738908
AN ISOLATED INTERLEUKIN-34 POLYPEPTIDE FOR USE IN PREVENTING TRANSPLANT REJECTION AND TREATING AUTOIMMUNE DISEASES
- IPC classification:
- A61K 38/20, A61P 37/06
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15731560
PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF OREXIN-1 RECEPTOR OX1R FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
- IPC classification:
- A61K 38/17, A61K 38/22, A61P 1/04, A61K 47/56
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ EXAMINATION REQUESTED
EP15744591
AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG
- IPC classification:
- A61P 37/06, C07K 16/28
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Examination is in progress
EP15760171
METHODS OF DIAGNOSING AND TREATING CANCER
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15766500
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS
- IPC classification:
- A61K 31/435, A61K 31/496, A61K 45/00, A61P 11/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15780771
IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY
- IPC classification:
- A61K 39/00, A61K 39/395, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15816218
METHODS FOR SCREENING A SUBJECT FOR A CANCER
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15790561
METHOD FOR IDENTIFYING IN A SUBJECT TUMOUR CELLS BEARING A T315I MUTATION
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Applicant:
- University of Poitiers (Université de Poitiers)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15794141
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
- IPC classification:
- A61K 31/435, A61K 31/47, A61K 31/5513, A61K 45/06, A61P 35/00
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15797960
METHODS OF DIAGNOSING CANCER AND OF PREDICTING RESPONSE OF CANCER TO DENDROGENIN A TREATMENT
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15800811
POLYPEPTIDES FOR THE TREATMENT OF ANGIOGENESIS OR LYMPHANGIOGENESIS-RELATED DISEASES
- IPC classification:
- A61K 38/00, C07K 14/705, C07K 16/28, C12N 15/62
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15798424
TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20R.
- IPC classification:
- A61K 39/00, C07K 16/24, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15798429
USE OF OX1R ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
- IPC classification:
- A61K 31/00, A61K 31/4545, A61P 1/08, A61P 1/12
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15808183
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTIONS
- IPC classification:
- A61K 31/7088, C12N 15/113
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Université Paris 6 Pierre et Marie Curie (UPMC)
- Applicant:
- Institut Gustave Roussy
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Applicant:
- Institut Pasteur - Transfert de technologie et entrepreneuriat
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15805233
HUMAN MONOCLONAL ANTIBODIES AGAINST AXL
- IPC classification:
- A61K 39/00, A61K 39/395, C07K 16/28
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Cabinet Plasseraud
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15817381
ALPHA-CELL RE-GENERATION COMBINED WITH CONVERSION TO BETA CELLS
- IPC classification:
- A61K 31/197, A61K 35/39, A61K 39/00, A61K 45/06, A61P 3/10, C12N 5/071
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15817861
METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR
- IPC classification:
- C07K 7/08, C07K 14/47
- Applicant:
- Université de Strasbourg
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15817376
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- IPC classification:
- A61K 38/16
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP15817338
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA
- IPC classification:
- A61K 38/16, A61P 31/04
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Droit et de la Santé de Lille 2
- Applicant:
- Université Lille 1 Sciences et Technologies
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16700152
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ISCHEMIC CONDITIONS
- IPC classification:
- A61K 38/16, A61K 38/17, A61K 38/18, A61K 38/49, A61K 45/06, A61P 9/10
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16700156
MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA
- IPC classification:
- A61K 38/36, A61K 38/48, C07K 14/745, C12N 9/64
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16700493
HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1
- IPC classification:
- A61K 39/00, C07K 16/28, C07K 16/30
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Institut régional du Cancer Montpellier / Val d’Aurelle
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16700495
HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1
- IPC classification:
- A61K 39/00, C07K 16/28, C07K 16/30
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Institut régional du Cancer Montpellier / Val d’Aurelle
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16700279
METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16702068
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EBOLA VIRUS DISEASE
- IPC classification:
- A61K 31/4965, A61P 31/14
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Bordeaux
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16702550
ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF
- IPC classification:
- A61K 39/12, C07K 16/18
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16704599
METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE
- IPC classification:
- A61K 38/18, C12Q 1/68, G01N 33/574
- Applicant:
- Université d'Angers
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Centre Hospitalier Universitaire d'Angers
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16704213
POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY
- IPC classification:
- A61K 48/00, C07K 19/00, C12N 9/22, C12N 15/62, C12N 15/867
- Applicant:
- CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16705174
METHODS FOR ON DEMAND PRE-EXPOSURE PROPHYLACTIC TREATMENT OF HIV INFECTION
- IPC classification:
- A61K 31/513, A61K 31/675, A61P 31/18
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Applicant:
- Université Paris Sud (UPS) Paris XI
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16705179
OREXIN-B POLYPEPTIDES AND USES THEREOF
- IPC classification:
- A61K 38/17
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paris Diderot - Paris 7
- Applicant:
- University of Montpellier (Université de Montpellier)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16707151
FGFR3 ANTAGONISTS
- IPC classification:
- A61K 31/4245, C07D 413/04
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Paris Descartes University (Université Paris Descartes - Paris V)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Assistance Publique Hôpitaux de Paris
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16707767
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV INFECTION
- IPC classification:
- A61K 31/7088, A61P 31/18, C12N 15/115
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université de Bordeaux
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16707709
NEW METHOD FOR TREATING AND PROGNOSING CANCER
- IPC classification:
- A61K 38/00, G01N 33/574
- Applicant:
- Université d'Angers
- Applicant:
- Université de Nantes
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16709394
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FILOVIRUS INFECTIONS
- IPC classification:
- A61K 31/7105, C12N 15/113, C12N 15/115
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université de Bordeaux
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16709287
ANTIBODIES SPECIFIC TO GLYCOPROTEIN (GP) OF EBOLA VIRUS AND USES FOR THE TREATMENT AND DIAGNOSIS OF EBOLA VIRUS INFECTION
- IPC classification:
- C07K 16/10
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Université Claude Bernard Lyon I (UCBL)
- Applicant:
- Ecole Normale Supérieure de Lyon
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16712794
METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF NEUROLOGICAL PHENOTYPE ASSOCIATED WITH FRIEDREICH ATAXIA
- IPC classification:
- A61K 48/00, C07K 14/47, C12N 15/86
- Applicant:
- Université de Strasbourg
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16712805
METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES
- IPC classification:
- A61K 38/17, A61P 3/10
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Université Paul Sabatier Toulouse III
- Applicant:
- Centre Hospitalier Universitaire de Toulouse
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made
EP16723255
NEW BIOMARKER FOR OUTCOME IN AML
- IPC classification:
- C12Q 1/68
- Applicant:
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Applicant:
- Centre National de la Recherche Scientifique (CNRS)
- Applicant:
- Aix-Marseille University (Université d'Aix-Marseille)
- Agent:
- Matthieu Collin, Inserm Transfert
- Status:
- █ Request for examination was made